Literature DB >> 21798217

Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient.

B Schlosser1, A Stein, R Neuhaus, S Pahl, B Ramez, D H Krüger, T Berg, J Hofmann.   

Abstract

Acute hepatitis E virus (HEV) infection is a self-limiting symptomatic or asymptomatic disease. However, as recently observed, it can manifest itself as chronic hepatitis in patients receiving solid organ transplants as well as in patients with HIV infection or severe hematologic disorders. Here, we describe the clinical course of a 73-year-old male patient in whom HEV transmission occurred after receiving a HEV-infected liver from a donor with occult HEV infection, whereby the patient had tested negative for HEV RNA and anti-HEV antibodies shortly before explantation. Anti-HEV IgG, IgM, and HEV RNA were detected in the first tested serum sample of the liver recipient obtained 150 days after liver transplantation and remained positive (earlier samples after OLT were not available). Liver cirrhosis developed within 15 months and the patient died of septic shock. Based on phylogenetic analyses of the donor and recipient's HEV strains, we were able to prove that the occult HEV infection was transmitted via the graft.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21798217     DOI: 10.1016/j.jhep.2011.06.021

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  60 in total

Review 1.  Hiding in Plain Sight? It's Time to Investigate Other Possible Transmission Routes for Hepatitis E Virus (HEV) in Developed Countries.

Authors:  Nicola J King; Joanne Hewitt; Anne-Marie Perchec-Merien
Journal:  Food Environ Virol       Date:  2018-04-05       Impact factor: 2.778

2.  Hepatitis E virus is an infrequent but potentially serious infection in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Lisa Swartling; Rickard Nordén; Ebba Samuelsson; Ksenia Boriskina; Davide Valentini; Johan Westin; Heléne Norder; Elda Sparrelid; Per Ljungman
Journal:  Bone Marrow Transplant       Date:  2020-02-18       Impact factor: 5.483

Review 3.  Clinical features and determinants of chronicity in hepatitis E virus infection.

Authors:  Shivakumar Narayanan; Ameer Abutaleb; Kenneth E Sherman; Shyam Kottilil
Journal:  J Viral Hepat       Date:  2019-02-05       Impact factor: 3.728

4.  Hepatitis E virus seroprevalence before hematopoietic SCT: a pediatric experience.

Authors:  M Jaber; K Béland; C Rousseau; S Cellot; U Halac; F Alvarez; C Buteau
Journal:  Bone Marrow Transplant       Date:  2014-03-17       Impact factor: 5.483

5.  Hepatitis E Virus.

Authors:  Georg Pauli; Martin Aepfelbacher; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Barbara Gärtner; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Uwe Schlenkrich; Volkmar Schottstedt; Rainer Seitz; Johanna Strobel; Hannelore Willkommen; Sally A Baylis
Journal:  Transfus Med Hemother       Date:  2015-06-01       Impact factor: 3.747

6.  An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication.

Authors:  Seong Eun Jin; Jung-Eun Kim; Sun Yeou Kim; Bang Ju Park; Yoon-Jae Song
Journal:  J Microbiol       Date:  2017-12-07       Impact factor: 3.422

Review 7.  Chronic hepatitis E: A brief review.

Authors:  Arvind R Murali; Vikram Kotwal; Saurabh Chawla
Journal:  World J Hepatol       Date:  2015-09-08

8.  Hepatitis E infection in HIV-infected liver and kidney transplant candidates.

Authors:  K E Sherman; N Terrault; B Barin; S D Rouster; M T Shata
Journal:  J Viral Hepat       Date:  2014-04-28       Impact factor: 3.728

9.  A nationwide retrospective study on prevalence of hepatitis E virus infection in Italian blood donors.

Authors:  Enea Spada; Simonetta Pupella; Giulio Pisani; Roberto Bruni; Paola Chionne; Elisabetta Madonna; Umbertina Villano; Matteo Simeoni; Sara Fabi; Giuseppe Marano; Cinzia Marcantonio; Patrizio Pezzotti; Anna R Ciccaglione; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2018-05-04       Impact factor: 3.443

10.  Epidemiology, diagnosis, vaccines, and bibliometric analysis of the 100 top-cited studies on Hepatitis E virus.

Authors:  Tauseef Ahmad; Saima Nasir; Taha Hussein Musa; Saif Aldeen S AlRyalat; Muhammad Khan; Jin Hui
Journal:  Hum Vaccin Immunother       Date:  2020-08-05       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.